Abstract
Objective
Numerous immune cell types, such as B and T lymphocytes, natural killer cells (NK), and NKT cells, are related to the pathogenesis of diseases in systemic lupus erythematosus (SLE). Our goal in this investigation is to examine the phenotype of NK cells and NKT cells alterations in individuals with SLE.
Methods
Typically, 50 SLE patients and 24 age-matched healthy people had their PBMCs obtained. Employing flow cytometry, the phenotype of NK and NKT cells and immunoglobulin-like transcript 2 (ILT2) expressions were identified. ELISA was utilized to evaluate the amounts of interleukin-15 (IL-15) and sHLA-G in the serum.
Results
The frequencies of the circulating NK and NKT cells in individuals with SLE were decreased compared to healthy controls. Furthermore, ILT2 expression was significantly increased in NKT cells, but showed no obvious change in NK cells. Clinical severity and active nephritis were substantially associated with ILT2+ NKT cell frequencies. The correlation study showed that the upregulation of ILT2 expression was related to sHLA-G in plasma but not to IL-15.
Conclusions
ILT2+ NKT cells have a vital function in the immune abnormalities of SLE, which can also supply a viable goal for therapeutic intervention.
Key Points •ILT2 expression was significantly increased in NKT cells in SLE patients. •ILT2+ NKT cell frequencies were associated with clinical severity which may be used as an indicator for evaluating disease activity in patients with SLE. |
Similar content being viewed by others
Data availability
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.
References
Tsokos GC (2011) Systemic lupus erythematosus. N Engl J Med 365:2110–2121
Dörner T, Furie R (2019) Novel paradigms in systemic lupus erythematosus. Lancet 393(10188):2344–2358
Suarez-fueyo A, Bradley SJ, Tsokos GC (2016) T cells in systemic lupus erythematosus. Curr Opin Immunol 43:32–38
Hervier B, Beziat V, Haroche J, Mathian A, Lebon P, Ghillani-Dalbin P et al (2011) Phenotype and function of natural killer cells in systemic lupus erythematosus. Arthritis Rheum 63(6):1698–1706
Spada R, Rojas JM, Barber DF (2015) Recent findings on the role of natural killer cells in the pathogenesis of systemic lupus erythematosus. J Leukoc Biol 98(4):479–487
Park YW, Kee SJ, Cho YN, Lee EH, Lee HY, Kim EM et al (2009) Impaired differentiation and cytotoxicity of natural killer cells in systemic lupus erythematosus. Arthritis rheum 60:1753–1763
Godfrey DI, Stankovic S, Baxter AG (2010) Raising the NKT cell family. Nat immunol 11:197–206
Green MR, Kennell AS, Larche MJ, Seifert MH, Isenberg DA, Salaman MR (2007) Natural killer T cells in families of patients with systemic lupus erythematosus: their possible role in regulation of IGG production. Arthritis rheum 56:303–310
Zhuang Y, Ning M, Ling Z, Zhen-Yu J, Yan-Fang J (2016) Differential expression of natural killer activating and inhibitory receptors in patients with newly diagnosed systemic lupus erythematosus. Int J Rheum Dis 19(6):613–621
Lucia N, Cristiana B, Cristina C, Serena R, Fulvia C, Marta V et al (2023) KLRG1 is reduced on NK cells in SLE patients, inversely correlates with disease activity and is modulated by hydroxychloroquine in vitro. Lupus 32(4):549–559
de Cruz-González DJ, Gómez-Martin D, Layseca-Espinosa E, Baranda L, Abud-Mendoza C, Alcocer-Varela J et al (2018) Analysis of the regulatory function of natural killer cells from patients with systemic lupus erythematosus. Clin Exp Immunol 191(3):288–300
Bellón T, Kitzig F, Sayós J, López-Botet M (2002) Mutational analysis of immunoreceptor tyrosine-based inhibition motifs of the Ig-like transcript 2 (CD85j) leukocyte receptor. J Immunol 168:3351–3359
Lamar DL, Weyand CM, Goronzy JJ (2010) Promoter choice and translational repression determine cell type-specific cell surface density of the inhibitory receptor CD85j expressed on different hematopoietic lineages. Blood 115:3278–3286
Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40(9):1725
Zahran AM, Abdel-Rahim MH, Elsayh KI, Hassanien MM, Mahran SA, Hetta HF (2019) Natural killer and natural killer t cells in juvenile systemic lupus erythematosus: relation to disease activity and progression. Arch Immuno Ther Ex 67:161–169
Liu M, Liu J, Zhang X, Xiao Y, Jiang G, Huang X (2021) Activation status of CD56(dim) natural killer cells is associated with disease activity of patients with systemic lupus erythematosus. Clin Rheumatol 40:1103–1112
Lin SJ, Kuo ML (2011) Cytotoxic function of umbilical cord blood natural killer cells: relevance to adoptive immunotherapy. Pediatr Hemat Oncol 28:640–646
Godfrey DI, Macdonald HR, Kronenberg M, Smyth MJ, Van Kaer L (2004) NKT cells: what’s in a name? Nat Rev Immunol 4:231–237
Lu Z, Tian Y, Bai Z, Liu J, Zhang Y, Qi J, Jin M, Zhu J, Li X (2022) Increased oxidative stress contributes to impaired peripheral CD56dimCD57+ NK cells from patients with systemic lupus erythematosus. Arthritis Res Ther 24(1):48
Manman L, Junli L, Xiaoyan Z, Yichuan X, Gengru J, Xinfang H (2021) Activation status of CD56dim natural killer cells is associated with disease activity of patients with systemic lupus erythematosus. Clin Rheumatol 40:1103–1112
Bosma A, Abdel-Gadir A, Isenberg DA, Jury EC, Mauri C (2012) Lipid-antigen presentation by CD1d(+) B cells is essential for the maintenance of invariant natural killer T cells. Immunity 36:477–490
Qing L, Yunyuan K, Biqi F, Xue L, Qingshui H, Zikun H et al (2022) Increased TIM-3+PD-1+ NK cells are associated with the disease activity and severity of systemic lupus erythematosus. Clin Exp Med 22(1):47–56
Hudspeth K, Wang S, Wang J, Rahman S, Smith MA, Casey KA et al (2019) Natural killer cell expression of Ki67 is associated with elevated serum IL-15, disease activity and nephritis in systemic lupus erythematosus. Clin Exp Immunol 196:226–236
Wong PT, Wong CK, Tam LS, Li EK, Chen DP, Lam CW (2009) Decreased expression of T lymphocyte co-stimulatory molecule CD26 on invariant natural killer T cells in systemic lupus erythematosus. Immunol Invest 38:350–364
Monsiváis-urenda A, Niño-moreno P, Abud-mendoza C, Baranda L, Layseca-espinosa E, López-botet M (2007) Analysis of expression and function of the inhibitory receptor ILT2 (CD85j/LILRB1/LIR-1) in peripheral blood mononuclear cells from patients with systemic lupus erythematosus (SLE). J Autoimmun 29:97–105
Figueroa-vega N, Galindo-rodríguez G, Bajaña S, Portales-Pérez D, Abud-mendoza C, Sánchez-torres C et al (2006) Phenotypic analysis of IL-10-treated, monocyte-derived dendritic cells in patients with systemic lupus erythematosus. Scand J Immunol 64:668–676
Chen J, Shen B, Jiang Y, Jun L, Zhu M, Chen B et al (2013) Analysis of immunoglobulin-like transcripts (ILTs) in lymphocytes with sHLA-G and IL10 from SLE patients. Clin Exp Med 13:135–142
Huntington ND, Legrand N, Alves NL, Jaron B, Weijer K, Plet A et al (2009) IL-15 trans-presentation promotes human NK cell development and differentiation in vivo. J Exp Med 206:25–34
Lin SJ, Kuo ML, Hsiao HS, Lee PT, Chen JY, Huang JL (2017) Activating and inhibitory receptors on natural killer cells in patients with systemic lupus erythematosis-regulation with interleukin-15. PLoS One 12:e0186223
Lin SJ, Kuo ML, Hsiao HS, Lee PT, Lee WI, Chen JY et al (2019) Cytotoxic function and cytokine production of natural killer cells and natural killer t-like cells in systemic lupus erythematosis regulation with interleukin-15. Mediators Inflamm 2019:4236562
D’almeida TC, Sadissou I, Cottrell G, Tahar R, Moreau P, Favier B et al (2016) Evolution of the levels of human leukocyte antigen G (HLA-G) in Beninese infant during the first year of life in a malaria endemic area: using latent class analysis. Malaria J 15:78
Rezaieyazdi Z, Rezaeian A, Khodashahi M (2023) Serum level of soluble human leukocyte antigen G in patients with systemic lupus erythematosus and rheumatoid arthritis. Curr Rheumatol Rev 19(1):64–71
Bae SC, Lee YH (2021) Association of HLA-G polymorphisms with systemic lupus erythematosus and correlation between soluble HLA-G levels and the disease: a meta-analysis. Z rheumatol 80:96–102
Funding
This study was supported by Natural Science Foundation of Fujian (no. 2022J011004, 2023J011178), Suzhou “Kejiaoxingwei” Youth Science and Technology project (KJXW2020004), and the Medical Innovation Project of Fujian (no. 2022CXB001).
Author information
Authors and Affiliations
Contributions
Ning Chen and Yijun Dai conceived and coordinated the study and wrote the paper. Qing Yan, Jun Ke, Jiuyun Zhang, and Hong Sun designed, performed and analyzed the experiments. Hui Li, Xianming Long, Fei Gao, and He Lin carried out the data collection, data analysis, and revised the paper. All authors reviewed the results and approved the final version of the manuscript.
Corresponding authors
Ethics declarations
Ethics approval and consent to participate
The study was approved by the ethics committee of Fujian Provincial Hospital. Written informed consent was obtained from all participants.
Disclosures
None.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Chen, N., Dai, Y., Li, H. et al. Increased ILT2+ natural killer T cells correlate with disease activity in systemic lupus erythematosus. Clin Rheumatol 42, 3113–3121 (2023). https://doi.org/10.1007/s10067-023-06750-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-023-06750-1